If you made any changes in Pure these will be visible here soon.

Research Output 1988 2019

  • 4216 Citations
  • 27 h-Index
  • 49 Article
  • 3 Chapter
Filter
Article
2019

An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome

Galbusera, M., Noris, M., Gastoldi, S., Bresin, E., Mele, C., Breno, M., Cuccarolo, P., Alberti, M., Valoti, E., Piras, R., Donadelli, R., Vivarelli, M., Murer, L., Pecoraro, C., Ferrari, E., Perna, A., Benigni, A., Portalupi, V. & Remuzzi, G., Mar 6 2019, In : American Journal of Kidney Diseases.

Research output: Contribution to journalArticle

Complement Membrane Attack Complex
Hemolytic-Uremic Syndrome
Complement Activation
Endothelium
Serum
2017
127 Citations (Scopus)

Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Goodship, T. H. J., Cook, H. T., Fakhouri, F., Fervenza, F. C., Frémeaux-Bacchi, V., Kavanagh, D., Nester, C. M., Noris, M., Pickering, M. C., Rodríguez de Córdoba, S., Roumenina, L. T., Sethi, S., Smith, R. J. H., Alpers, C. E., Appel, G. B., Ardissino, G., Ariceta, G., Arici, M., Bagga, A., Bajema, I. M. & 33 others, Blasco, M., Burke, L., Cairns, T. D., Carratala, M., D'Agati, V. D., Daha, M. R., De Vriese, A. S., Dragon-Durey, M. A., Fogo, A. B., Galbusera, M., Gale, D. P., Haller, H., Johnson, S., Józsi, M., Karpman, D., Lanning, L., Le Quintrec, M., Licht, C., Loirat, C., Monfort, F., Morgan, B. P., Noël, L. H., O'Shaughnessy, M. M., Rabant, M., Rondeau, E., Ruggenenti, P., Sheerin, N. S., Smith, J., Spoleti, F., Thurman, J. M., van de Kar, N. C. A. J., Vivarelli, M. & Zipfel, P. F., Mar 1 2017, In : Kidney International. 91, 3, p. 539-551 13 p.

Research output: Contribution to journalArticle

Kidney Diseases
Inborn Genetic Diseases
Complement C3
Clinical Pathology
Disease Management
12 Citations (Scopus)

Interaction between multimeric von willebrand factor and complement: A fresh look to the pathophysiology of microvascular thrombosis

Bettoni, S., Galbusera, M., Gastoldi, S., Donadelli, R., Tentori, C., Spartà, G., Bresin, E., Mele, C., Alberti, M., Tortajada, A., Yebenes, H., Remuzzi, G. & Noris, M., Aug 1 2017, In : Journal of Immunology. 199, 3, p. 1021-1040 20 p.

Research output: Contribution to journalArticle

Thrombotic Thrombocytopenic Purpura
von Willebrand Factor
Thrombosis
Alternative Complement Pathway
Complement Membrane Attack Complex
2016
12 Citations (Scopus)

Liver transplantation for aHUS: still needed in the eculizumab era?

Coppo, R., Bonaudo, R., Peruzzi, R. L., Amore, A., Brunati, A., Romagnoli, R., Salizzoni, M., Galbusera, M., Gotti, E., Daina, E., Noris, M. & Remuzzi, G., 2016, In : Pediatric Nephrology. 31, p. 759-768

Research output: Contribution to journalArticle

Liver Transplantation
Transplants
Complement Factor H
Kidney
Liver
2015
10 Citations (Scopus)
Thrombotic Thrombocytopenic Purpura
Kidney
Confidence Intervals
Odds Ratio
Metalloproteases
9 Citations (Scopus)

Mitochondrial-dependent Autoimmunity in Membranous Nephropathy of IgG4-related Disease

Buelli, S., Perico, L., Galbusera, M., Abbate, M., Morigi, M., Novelli, R., Gagliardini, E., Tentori, C., Rottoli, D., Sabadini, E., Saito, T., Kawano, M., Saeki, T., Zoja, C., Remuzzi, G. & Benigni, A., May 1 2015, In : EBioMedicine. 2, 5, p. 456-466 11 p.

Research output: Contribution to journalArticle

Membranous Glomerulonephritis
Autoimmunity
Immunoglobulin G
Carbonic Anhydrase II
Podocytes
17 Citations (Scopus)

Treatment of congenital thrombotic thrombocytopenic purpura with eculizumab

Pecoraro, C., Ferretti, A. V. S., Rurali, E., Galbusera, M., Noris, M. & Remuzzi, G., Dec 1 2015, In : American Journal of Kidney Diseases. 66, 6, p. 1067-1070 4 p.

Research output: Contribution to journalArticle

Thrombotic Thrombocytopenic Purpura
Complement Activation
Shiga Toxins
Genes
Shiga-Toxigenic Escherichia coli
2014
7 Citations (Scopus)

A novel antibody against human factor B that blocks formation of the C3bB proconvertase and inhibits complement activation in disease models

Subías, M., Tortajada, A., Gastoldi, S., Galbusera, M., López-Perrote, A., De Juana Lopez, L., González-Fernández, F. A., Villegas-Martínez, A., Dominguez, M., Llorca, O., Noris, M., Morgan, B. P. & De Córdoba, S. R., Dec 1 2014, In : Journal of Immunology. 193, 11, p. 5567-5575 9 p.

Research output: Contribution to journalArticle

Complement Factor B
Complement Activation
Alternative Pathway Complement C3 Convertase
Complement Inactivating Agents
Hemolysis
131 Citations (Scopus)

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy.

Noris, M., Galbusera, M., Gastoldi, S., Macor, P., Banterla, F., Bresin, E., Tripodo, C., Bettoni, S., Donadelli, R., Valoti, E., Tedesco, F., Amore, A., Coppo, R., Ruggenenti, P., Gotti, E. & Remuzzi, G., 2014, In : Blood. 124, 11, p. 1715-1726 12 p.

Research output: Contribution to journalArticle

Complement Membrane Attack Complex
Complement Activation
Deposits
Chemical activation
Serum
2013
21 Citations (Scopus)

ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapy

Rurali, E., Noris, M., Chianca, A., Donadelli, R., Banterla, F., Galbusera, M., Gherardi, G., Gastoldi, S., Parvanova, A., Iliev, I., Bossi, A., Haefliger, C., Trevisan, R., Remuzzi, G. & Ruggenenti, P., Oct 2013, In : Diabetes. 62, 10, p. 3599-3609 11 p.

Research output: Contribution to journalArticle

Angiotensin-Converting Enzyme Inhibitors
Kidney
Homozygote
von Willebrand Factor
Therapeutics
27 Citations (Scopus)

Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations

Alberti, M., Valoti, E., Piras, R., Bresin, E., Galbusera, M., Tripodo, C., Thaiss, F., Remuzzi, G. & Noris, M., Aug 2013, In : American Journal of Transplantation. 13, 8, p. 2201-2206 6 p.

Research output: Contribution to journalArticle

Shiga-Toxigenic Escherichia coli
Hemolytic-Uremic Syndrome
Recurrence
Mutation
Genes
2011
149 Citations (Scopus)

Alternative pathway activation of complement by shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis

Morigi, M., Galbusera, M., Gastoldi, S., Locatelli, M., Buelli, S., Pezzotta, A., Pagani, C., Noris, M., Gobbi, M., Stravalaci, M., Rottoli, D., Tedesco, F., Remuzzi, G. & Zoja, C., Jul 1 2011, In : Journal of Immunology. 187, 1, p. 172-180 9 p.

Research output: Contribution to journalArticle

Shiga Toxin
Alternative Complement Pathway
Hemolytic-Uremic Syndrome
P-Selectin
Thrombosis
56 Citations (Scopus)

Membranous nephropathy associated with IgG4-related disease

Cravedi, P., Abbate, M., Gagliardini, E., Galbusera, M., Buelli, S., Sabadini, E., Maras, M., Beck, L. H., Salant, D. J., Benigni, A., D'Agati, V. & Remuzzi, G., Aug 2011, In : American Journal of Kidney Diseases. 58, 2, p. 272-275 4 p.

Research output: Contribution to journalArticle

Membranous Glomerulonephritis
Immunoglobulins
Kidney
Phospholipase A2 Receptors
Mikulicz' Disease
2009
9 Citations (Scopus)

Adenoviral-mediated gene transfer restores plasma ADAMTS13 antigen and activity in ADAMTS13 knockout mice

Trionfini, P., Tomasoni, S., Galbusera, M., Motto, D., Longaretti, L., Corna, D., Remuzzi, G. & Benigni, A., 2009, In : Gene Therapy. 16, 11, p. 1373-1379 7 p.

Research output: Contribution to journalArticle

Knockout Mice
Thrombotic Thrombocytopenic Purpura
Antigens
Genes
Human Adenoviruses
25 Citations (Scopus)

Inherited thrombotic thrombocytopenic purpura

Galbusera, M., Noris, M. & Remuzzi, G., Feb 2009, In : Haematologica. 94, 2, p. 166-170 5 p.

Research output: Contribution to journalArticle

60 Citations (Scopus)

Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies

Bresin, E., Gastoldi, S., Daina, E., Belotti, D., Pogliani, E., Perseghin, P., Scalzulli, P. R., Paolini, R., Marcenò, R., Remuzzi, G. & Galbusera, M., Feb 2009, In : Thrombosis and Haemostasis. 101, 2, p. 233-238 6 p.

Research output: Contribution to journalArticle

Thrombotic Thrombocytopenic Purpura
Autoantibodies
Recurrence
Therapeutics
Hemolytic Anemia
87 Citations (Scopus)

Treatment of bleeding in dialysis patients

Galbusera, M., Remuzzi, G. & Boccardo, P., May 2009, In : Seminars in Dialysis. 22, 3, p. 279-286 8 p.

Research output: Contribution to journalArticle

Dialysis
Blood Platelets
Hemorrhage
Uremia
Therapeutics
2007
53 Citations (Scopus)

Involvement of renal tubular toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus

Benigni, A., Caroli, C., Longaretti, L., Gagliardini, E., Zoja, C., Galbusera, M., Moioli, D., Romagnani, P., Tincani, A., Andreoli, L. & Remuzzi, G., May 2007, In : Arthritis and Rheumatism. 56, 5, p. 1569-1578 10 p.

Research output: Contribution to journalArticle

Toll-Like Receptor 9
Kidney
Wounds and Injuries
Lupus Nephritis
Antigen-Antibody Complex
2006
62 Citations (Scopus)

In-vitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTS13 in thrombotic trombocytopenic purpura

Donadelli, R., Banterla, F., Galbusera, M., Capoferri, C., Bucchioni, S., Gastoldi, S., Nosari, S., Monteferrante, G., Ruggeri, Z. M., Bresin, E., Scheiflinger, F., Rossi, E., Martinez, C., Coppo, R., Remuzzi, G. & Noris, M., Oct 2006, In : Thrombosis and Haemostasis. 96, 4, p. 454-464 11 p.

Research output: Contribution to journalArticle

Purpura
Mutation
Thrombotic Thrombocytopenic Purpura
Peptide Hydrolases
Drosophila
46 Citations (Scopus)

Thrombotic thrombocytopenic purpura - Then and now

Galbusera, M., Noris, M. & Remuzzi, G., Mar 2006, In : Seminars in Thrombosis and Hemostasis. 32, 2, p. 81-89 9 p.

Research output: Contribution to journalArticle

Thrombotic Thrombocytopenic Purpura
Endothelial Cells
Megakaryocytes
Hemolytic Anemia
von Willebrand Factor
2005
11 Citations (Scopus)

Activation of porcine endothelium in response to xenogeneic serum causes thrombosis independently of platelet activation

Galbusera, M., Buelli, S., Gastoldi, S., Macconi, D., Angioletti, S., Testa, C., Remuzzi, G. & Morigi, M., Mar 2005, In : Xenotransplantation. 12, 2, p. 110-120 11 p.

Research output: Contribution to journalArticle

Platelet Activation
Endothelium
Thrombosis
Swine
Endothelial Cells
200 Citations (Scopus)

ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases

Rieger, M., Mannucci, P. M., Kremer Hovinga, J. A., Herzog, A., Gerstenbauer, G., Konetschny, C., Zimmermann, K., Scharrer, I., Peyvandi, F., Galbusera, M., Remuzzi, G., Böhm, M., Plaimauer, B., Lämmle, B. & Scheiflinger, F., Aug 15 2005, In : Blood. 106, 4, p. 1262-1267 6 p.

Research output: Contribution to journalArticle

Thrombotic Microangiopathies
Autoantibodies
Antibodies
Assays
Immunosorbents
72 Citations (Scopus)

Complement activation: The missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies

Ruiz-Torres, M. P., Casiraghi, F., Galbusera, M., Macconi, D., Gastoldi, S., Todeschini, M., Porrati, F., Belotti, D., Pogliani, E. M., Noris, M. & Remuzzi, G., Mar 2005, In : Thrombosis and Haemostasis. 93, 3, p. 443-452 10 p.

Research output: Contribution to journalArticle

Thrombotic Microangiopathies
Complement Activation
Thrombosis
Serum
Reactive Oxygen Species
105 Citations (Scopus)

Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement

Noris, M., Bucchioni, S., Galbusera, M., Donadelli, R., Bresin, E., Castelletti, F., Caprioli, J., Brioschi, S., Scheiflinger, F. & Remuzzi, G., 2005, In : Journal of the American Society of Nephrology. 16, 5, p. 1177-1183 7 p.

Research output: Contribution to journalArticle

Complement Factor H
Thrombotic Thrombocytopenic Purpura
Siblings
Kidney
Mutation
114 Citations (Scopus)

In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: Implication for permselective dysfunction of chronic nephropathies

Morigi, M., Buelli, S., Angioletti, S., Zanchi, C., Longaretti, L., Zoja, C., Galbusera, M., Gastoldi, S., Mundel, P., Remuzzi, G. & Benigni, A., May 2005, In : American Journal of Pathology. 166, 5, p. 1309-1320 12 p.

Research output: Contribution to journalArticle

Podocytes
Endothelin-1
Cytoskeleton
Focal Adhesion Protein-Tyrosine Kinases
rho-Associated Kinases
53 Citations (Scopus)

Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: A case report

Galbusera, M., Bresin, E., Noris, M., Gastoldi, S., Belotti, D., Capoferri, C., Daina, E., Perseghin, P., Scheiflinger, F., Fakhouri, F., Grünfeld, J. P., Pogliani, E. & Remuzzi, G., Aug 1 2005, In : Blood. 106, 3, p. 925-928 4 p.

Research output: Contribution to journalArticle

Thrombotic Thrombocytopenic Purpura
Plasma Exchange
Plasmas
Recurrence
Peptide Hydrolases
2004
84 Citations (Scopus)

Measurement of von Willebrand factor cleaving protease (ADAMST-13): Results of an international collaborative study involving 11 method testing the same set of coded plasmas

Tripodi, A., Chantarangkul, V., Böhm, M., Budde, U., Dong, J. F., Friedman, K. D., Galbusera, M., Girma, J. P., Moake, J., Rick, M. E., Studt, J. D., Turecek, P. L. & Mannucci, P. M., Sep 2004, In : Journal of Thrombosis and Haemostasis. 2, 9, p. 1601-1609 9 p.

Research output: Contribution to journalArticle

Thrombotic Thrombocytopenic Purpura
Dry Ice
ADAMTS13 Protein
Hemolytic-Uremic Syndrome
von Willebrand Factor
236 Citations (Scopus)

Platelet dysfunction in renal failure

Boccardo, P., Remuzzi, G. & Galbusera, M., Oct 2004, In : Seminars in Thrombosis and Hemostasis. 30, 5, p. 579-589 11 p.

Research output: Contribution to journalArticle

Renal Insufficiency
Blood Platelets
Hemorrhage
Thrombosis
Hemostatic Disorders
2003
1 Citation (Scopus)

Mecanismos del daño endotelial en la microangiopatía trombótica

Translated title of the contribution: Endothelial dysfunction mechanisms in thrombotic microangiopathyRuiz-Torres, M. P., Casighari, F., Noris, M., Macconi, D., Galbusera, M. & Remuzzi, G., 2003, In : Nefrologia. 23, SUPPL.3, p. 25-27 3 p.

Research output: Contribution to journalArticle

2002
18 Citations (Scopus)

Deficiency of ADAMTS13 and thrombotic thrombocytopenic purpura [2] (multiple letters)

Tsai, H. M., Lämmle, B., Bianchi, V., Alberio, L., Furlan, M., Remuzzi, G., Galbusera, M. & Mannucci, P. M., Nov 15 2002, In : Blood. 100, 10, p. 3839-3842 4 p.

Research output: Contribution to journalArticle

172 Citations (Scopus)

Von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

Remuzzi, G., Galbusera, M., Noris, M., Canciani, M. T., Daina, E., Bresin, E., Contaretti, S., Caprioli, J., Gamba, S., Ruggenenti, P., Perico, N. & Mannucci, P. O., Aug 1 2002, In : Blood. 100, 3, p. 778-785 8 p.

Research output: Contribution to journalArticle

Thrombotic Thrombocytopenic Purpura
Hemolytic-Uremic Syndrome
von Willebrand Factor
Peptide Hydrolases
Plasmas
2001
74 Citations (Scopus)

Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress

Morigi, M., Galbusera, M., Binda, E., Imberti, B., Gastoldi, S., Remuzzi, A., Zoja, C. & Remuzzi, G., Sep 15 2001, In : Blood. 98, 6, p. 1828-1835 8 p.

Research output: Contribution to journalArticle

Shiga Toxins
Endothelial cells
Adhesives
Shear stress
Thrombosis
2000
8 Citations (Scopus)
Thrombotic Microangiopathies
von Willebrand Factor
Thrombosis
Blood Platelets
Platelet Glycoprotein GPIb-IX Complex
1999
43 Citations (Scopus)

Increased fragmentation of von Willebrand factor, due to abnormal cleavage of the subunit, parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and discloses predisposition in families

Galbusera, M., Noris, M., Rossi, C., Orisio, S., Caprioli, J., Ruggeri, Z. M., Amadei, B., Ruggenenti, P., Vasile, B., Casari, G. & Remuzzi, G., Jul 15 1999, In : Blood. 94, 2, p. 610-620 11 p.

Research output: Contribution to journalArticle

Thrombotic Thrombocytopenic Purpura
Hemolytic-Uremic Syndrome
von Willebrand Factor
Molecular mass
Blood
126 Citations (Scopus)

Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor

Falanga, A., Marchetti, M., Evangelista, V., Manarini, S., Oldani, E., Giovanelli, S., Galbusera, M., Cerletti, C. & Barbui, T., Apr 15 1999, In : Blood. 93, 8, p. 2506-2514 9 p.

Research output: Contribution to journalArticle

Neutrophil Activation
Granulocyte Colony-Stimulating Factor
Hemostatics
Chemical activation
Pancreatic Elastase
23 Citations (Scopus)
Thrombotic Thrombocytopenic Purpura
Hemolytic-Uremic Syndrome
von Willebrand Factor
Molecular Weight
Antigens
1998
1368 Citations (Scopus)

Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

Furlan, M., Robles, R., Galbusera, M., Remuzzi, G., Kyrle, P. A., Brenner, B., Krause, M., Scharrer, I., Aumann, V., Mittler, U., Solenthaler, M. & Lämmle, B., Nov 26 1998, In : New England Journal of Medicine. 339, 22, p. 1578-1584 7 p.

Research output: Contribution to journalArticle

Thrombotic Thrombocytopenic Purpura
Hemolytic-Uremic Syndrome
von Willebrand Factor
Peptide Hydrolases
ADAMTS13 Protein
1997
114 Citations (Scopus)

Fluid shear stress modulates von Willebrand factor release from human vascular endothelium

Galbusera, M., Zoja, C., Donadelli, R., Paris, S., Morigi, M., Benigni, A., Figliuzzi, M., Remuzzi, G. & Remuzzi, A., Aug 15 1997, In : Blood. 90, 4, p. 1558-1564 7 p.

Research output: Contribution to journalArticle

Vascular Endothelium
von Willebrand Factor
Shear stress
Fluids
Endothelial cells
1996
43 Citations (Scopus)

Bilateral nephrectomy stopped disease progression in plasma-resistant hemolytic uremic syndrome with neurological signs and coma

Remuzzi, G., Galbusera, M., Salvadori, M., Rizzoni, G., Paris, S. & Ruggenenti, P., 1996, In : Kidney International. 49, 1, p. 282-286 5 p.

Research output: Contribution to journalArticle

Hemolytic-Uremic Syndrome
von Willebrand Factor
Coma
Nephrectomy
Disease Progression
1995
16 Citations (Scopus)

α1-antitrypsin therapy in a case of thrombotic thrombocytopenic purpura

Galbusera, M., Ruggenenti, P., Noris, M., Benigni, A., Remuzzi, G., Ruggenenti, P., Remuzzi, G., Burnouf-Radosevich, M. & Mannucci, P. M., Jan 28 1995, In : Lancet. 345, 8944, p. 224-225 2 p.

Research output: Contribution to journalArticle

Thrombotic Thrombocytopenic Purpura
von Willebrand Factor
Leukocyte Elastase
Platelet Count
Therapeutics
1994

About the cover illustration Platelet adhsion

Remuzzi, A. & Galbusera, M., Jul 1994, In : The Journal of Laboratory and Clinical Medicine. 124, 1, p. 142 1 p.

Research output: Contribution to journalArticle

1993
80 Citations (Scopus)

Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia

Benigni, A., Boccardo, P., Galbusera, M., Monteagudo, J., De Marco, L., Remuzzi, G. & Ruggeri, Z. M., 1993, In : American Journal of Kidney Diseases. 22, 5, p. 668-676 9 p.

Research output: Contribution to journalArticle

Integrin beta3
Platelet Glycoprotein GPIIb-IIIa Complex
Uremia
Blood Platelets
von Willebrand Factor
61 Citations (Scopus)

Thrombotic thrombocytopenic purpura: Evidence that infusion rather than removal of plasma induces remission of the disease

Ruggenenti, P., Galbusera, M., Cornejo, R. P., Bellavita, P. & Remuzzi, G., 1993, In : American Journal of Kidney Diseases. 21, 3, p. 314-318 5 p.

Research output: Contribution to journalArticle

Thrombotic Thrombocytopenic Purpura
Plasma Exchange
Recurrence
von Willebrand Factor
Protease Inhibitors
1992
17 Citations (Scopus)

Defective platelet aggregation in response to platelet-activating factor in uremia associated with low platelet thromboxane A2 generation

Macconi, D., Vigano, G., Bisogno, G., Galbusera, M., Orisio, S., Remuzzi, G. & Livio, M., 1992, In : American Journal of Kidney Diseases. 19, 4, p. 318-325 8 p.

Research output: Contribution to journalArticle

Thromboxane A2
Uremia
Platelet Activating Factor
Platelet Aggregation
Blood Platelets
1991
164 Citations (Scopus)

Heterogeneity of plasma von willebrand factor multimers resulting from proteolysis of the constituent subunit

Dent, J. A., Galbusera, M. & Ruggeri, Z. M., 1991, In : Journal of Clinical Investigation. 88, 3, p. 774-782 9 p.

Research output: Contribution to journalArticle

von Willebrand Factor
Proteolysis
Blood Platelets
Type 2 von Willebrand Disease
Agar Gel Electrophoresis
1990
13 Citations (Scopus)

Functional implications of decreased renal cortical atrial natriuretic peptide binding in experimental diabetes

Benigni, A., Perico, N., Dadan, J., Gabanelli, M., Galbusera, M., Boccardo, P., Mennini, T. & Remuzzi, G., 1990, In : Circulation Research. 66, 6, p. 1453-1460 8 p.

Research output: Contribution to journalArticle

Atrial Natriuretic Factor
Atrial Natriuretic Factor Receptors
Kidney
Plasma Volume
Down-Regulation
1989
46 Citations (Scopus)

Blunted excretory response to atrial natriuretic peptide in experimental nephrosis

Perico, N., Delaini, F., Lupini, C., Benigni, A., Galbusera, M., Boccardo, P. & Remussi, G., 1989, In : Kidney International. 36, 1, p. 57-64 8 p.

Research output: Contribution to journalArticle

Nephrosis
Atrial Natriuretic Factor
Doxorubicin
Atrial Natriuretic Factor Receptors
Kidney
1988
23 Citations (Scopus)

Catecholamine receptor binding in rat kidney: Effect of aging

Galbusera, M., Garattini, S., Remuzzi, G. & Mennini, T., 1988, In : Kidney International. 33, 6, p. 1073-1077 5 p.

Research output: Contribution to journalArticle

Catecholamine Receptors
Adrenergic Receptors
Kidney
Binding Sites
Spiperone
10 Citations (Scopus)

Role of platelet-activating factor in primary hemostasis

Livio, M., Vigano, G., Morigi, M., Ubiali, A., Galbusera, M. & Remuzzi, G., 1988, In : American Journal of Physiology - Heart and Circulatory Physiology. 254, 6

Research output: Contribution to journalArticle

2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran
Platelet Activating Factor
Hemostasis
Bleeding Time
Rabbits